# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Vorinostat (SAHA, MK0683) | SAHA | FC | = | 2.5 | ALA4268537 | Plasmodium falciparum 3D7 | |||||
2. | Vorinostat (SAHA, MK0683) | SAHA | FC | = | 2.5 | ALA4268536 | Plasmodium falciparum 3D7 | |||||
3. | ALA4278449 | 1v | FC | = | 1 | ALA4268535 | Plasmodium falciparum 3D7 | |||||
4. | 4-[[[2-(cyclohexylamino)-2-oxoethyl]-(4-propan-2-ylbenzoyl)amino]methyl]-N-hydroxybenzamide | 1u | FC | = | 1 | ALA4268535 | Plasmodium falciparum 3D7 | |||||
5. | ALA4281918 | 1t | FC | = | 1 | ALA4268535 | Plasmodium falciparum 3D7 | |||||
6. | ALA4283545 | 1q | FC | = | 1 | ALA4268535 | Plasmodium falciparum 3D7 | |||||
7. | ALA4276668 | 1m | FC | = | 1 | ALA4268535 | Plasmodium falciparum 3D7 | |||||
8. | ALA4162282 | 2 | FC | = | 2 | ALA4268535 | Plasmodium falciparum 3D7 | |||||
9. | ALA4173361 | 1 | FC | = | 1 | ALA4268535 | Plasmodium falciparum 3D7 | |||||
10. | Vorinostat (SAHA, MK0683) | SAHA | FC | = | 2.5 | ALA4268535 | Plasmodium falciparum 3D7 | |||||
11. | ALA4289151 | 1a | FC | = | 1 | ALA4268535 | Plasmodium falciparum 3D7 | |||||
12. | ALA4288073 | 1d | FC | = | 2 | ALA4268535 | Plasmodium falciparum 3D7 | |||||
13. | ALA4280840 | 1g | FC | = | 1 | ALA4268535 | Plasmodium falciparum 3D7 | |||||
14. | ALA4063658 | 2i-cis | FC | = | 2 | ALA4268535 | Plasmodium falciparum 3D7 | |||||
15. | ALA468935 | 4 | INH | 0 | ALA1637566 | Dose-dependent effect | % | Plasmodium falciparum 3D7 | ||||
16. | Vorinostat (SAHA, MK0683) | SAHA | IC50 | = | 100 | nM | ALA1637566 | 7.00 | nM | Plasmodium falciparum 3D7 | ||
17. | ALA99 | TSA | INH | 0 | ALA1637563 | Active | % | Plasmodium falciparum 3D7 | ||||
18. | ALA567597 | 1 | INH | 0 | ALA1637564 | Not Active | % | Plasmodium falciparum 3D7 | ||||
19. | ALA567597 | 1 | INH | 0 | ALA1293139 | Not Active | % | Plasmodium falciparum 3D7 | ||||
20. | ALA220692 | 53 | INH | 0 | ALA1293140 | Dose-dependent effect | % | Plasmodium falciparum 3D7 |